We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Discoid drug‐induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review.
- Authors
Brehon, Alice; Moguelet, Philippe; Guégan, Sarah; Abisror, Noémie; Barbaud, Annick; Beal, Caroline; Laffitte, Emmanuel; Fain, Olivier; Francès, Camille; Chasset, François
- Abstract
Discoid drug-induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review Drug-induced lupus erythematosus (DILE) is a lupus-like autoimmune disorder, which usually occurs with chronic exposure to certain drugs and resolves after cessation of the culprit medication.[1] The spectrum of DILE constantly evolves with that of the pharmacopeia.[1] In a recent study of 12 166 DILE identified from the WHO pharmacovigilance database, 118 drugs were identified.[2] This study showed that since 2007, antitumor necrosis factor (anti-TNF) agents have been the drugs most commonly associated with systemic DILE.[2] Such as idiopathic lupus, DILE can be classified in systemic and cutaneous DILE. The refractory features could raise the hypothesis of a classical systemic lupus erythematosus occurring under anti-TNF rather than a DILE.
- Subjects
LUPUS erythematosus; LITERATURE reviews; DNA antibodies; SYSTEMIC lupus erythematosus; IMMUNOSUPPRESSIVE agents; NECROSIS
- Publication
Dermatologic Therapy, 2020, Vol 33, Issue 3, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.13364